GU CONNECT is an international group of experts in the field of genitourinary oncology and is an initiative of COR2ED. The group discusses the latest scientific and clinical insights, identifies educational needs, and develops educational programmes to support healthcare professionals globally to provide the best possible care to their patients.
GU CONNECT is an initiative of COR2ED, supported by Independent Educational Medical Grants from Bayer, AstraZeneca and Eisai Europe Limited.
What’s new from GU CONNECT
Conference update
RCC Update from ESMO 2023
How will the latest data impact clinical practice?
Experts
Prof. Laurence Albiges-
Downloadable
Resources -
4 MIN
-
Oct 2023
Micro learning
Module
2
of 2
PARP inhibitors in prostate cancer and the rationale behind combination treatment
Module 2 - Evolving landscape of PARPi in mCRPC: Combination with anti-androgens
Experts
Assoc. Prof. Alicia Morgans, Dr Pasquale RescignoEndorsed by
-
Downloadable
Resources -
4 MIN
-
Oct 2023
Interactive patient case
Optimising treatment for advanced RCC
Journey through an interactive patient case
Experts
Prof. Viktor Grünwald-
15 MIN
-
Oct 2023
Video
Episode
2
of 2
Clinical implementation of testing and PARPis in combination with NHAs
Episode 2: Clinical implementation of testing and PARP inhibitors in combination with NHAs
Experts
Dr Andrew J. ArmstrongEndorsed by
-
Downloadable
Resources -
5 MIN
-
Jul 2023
Video
Episode
1
of 2
Clinical implementation of testing and PARPi as monotherapy
Episode 1: Clinical implementation of testing and PARPi monotherapy
Experts
Dr Neal ShoreEndorsed by
-
Downloadable
Resources -
5 MIN
-
Jul 2023
Video
Update from ASCO 2023: Late-Breaking RCC Data
Prof. Thomas Powles shares his perspective on key RCC data
Experts
Prof. Thomas Powles-
Downloadable
Resources -
3 MIN
-
Jun 2023
